Phil first learned about the MMRF Road to Victories event in 2019 when he accompanied his wife to Vermont for her participation. He met many of the R2V Team members and staff and knew that he wanted to be a part of this incredible event.
Later that fall Phil learned that his co-worker, Tom Fadden, CFO, of Haughn Insurance had been diagnosed with Multiple Myeloma. Phil is riding to support and honor Tom’s incredible spirit as he battles his MM with positivity and a great sense of humor.
As an avid cyclist for more than 30 years Phil has been involved in supporting various causes in his community. He coached for The Leukemia and Lymphoma Society’s Team in Training program for 5 seasons and serves on The Pedal with Pete Foundation Board, supporting Cerebral Palsy research. Training for the ride’s challenges and fundraising for MMRF to support research for Multiple Myeloma and patient support are a mission he is pursuing with great passion and determination.
At Janssen Oncology, we’re shaping the future of cancer treatment. In the process, we’re striving to change expectations of what a cancer diagnosis means. Our purpose is driven by an urgency and commitment to bringing transformational cancer solutions to the people who need them. Passionate about our work, we are driven by the personal connection many of us share with the disease. With our partners, we focus on delivering solutions that make a positive impact on human health. We are part of Janssen Biotech, Inc., and the Janssen Pharmaceutical Companies of Johnson & Johnson.
About Janssen OncologyClick below to learn more about a treatment option for multiple myeloma. If you’re also interested in getting more information from Janssen, sign up for ongoing communications.
Learn More
